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Abstract
Background:  Plasmodium falciparum, the most dangerous malaria parasite species to humans remains an important public health 
concern in Okelele, a rural community in Ilorin, Kwara State, Nigeria.  There is however little information about the genetic 
diversity of  Plasmodium falciparum in Nigeria.
Objective: To determine the population genomic diversity of  Plasmodium falciparum in malaria patients attending Okelele Com-
munity Healthcare Centre, Okelele, Ilorin, Kwara State.
Methods: In this study, 50 Plasmodium falciparum strains Merozoite Surface Protein 1, Merozoite Surface Protein 2 and Glutamate 
Rich Protein were analysed from Okelele Health Centre, Okelele, Ilorin, Nigeria. Genetic diversity of  P. falciparum isolates were 
analysed from nested polymerase chain reactions (PCR) of  the MSP-1 (K1, MAD 20 and RO33), MSP-2 (FC27 and 3D7) and 
Glutamate Rich Protein allelic families respectively.
Results: Polyclonal infections were more in majority of  the patients for MSP-1 allelic families while monoclonal infections were 
more for MSP-2 allelic families.  Multiplicity of  infection for MSP-1, MSP-2 and GLURP were 1.7, 1.8 and 2.05 respectively
Conclusion: There is high genetic diversity in MSP – 2 and GLURP allelic families of  Plasmodium falciparum isolates from Okelele 
Health Centre, Ilorin, Nigeria.
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Introduction
Malaria is a life-threatening disease caused by Plasmodium 
parasites that is transmitted to people through the bites 
of  infected female Anopheles mosquitoes.  There are five 
types of  Plasmodium spp. causing malaria in humans.  These 
are Plasmodium falciparum, Plasmodium vivax, Plasmodium ma-
lariae, Plasmodium ovale and the zoonotic species Plasmo-
dium knowlesi.1 Among the malarial parasites, Plasmodium 
falciparum causes the most severe malarial attacks and is 
responsible for the high morbidity and mortality, frequent 
antimalarial drug resistance and aborted vaccines trials.2,3 
Genetic diversity of  Plasmodium falciparum plays an impor-
tant role in determining the intensity of  malaria transmis-
sion. Several P. falciparum genes show extensive genetic 
polymorphism, however, high polymorphism has been 
shown in Merozoite surface proteins 1 and 2 (MSP-1 and 
MSP-2) and Glutamate Rich Protein (GLURP) in dif-
ferent qeographical locations in malaria endemic areas. 
MSP-1, MSP-2 and GLURP genes are widely used to 
study the allelic diversity and frequency of  P. Falciparum.4,5
Merozoite surface protein-1 (MSP-1) of  P. falciparum is 
a major surface protein, with an approximate molecular 
size of  190 kDa that plays an important role in erythro-
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cyte invasion by the merozoite.6 The protein is a principal 
target of  human immune responses7 and is a promising 
candidate for a blood stage subunit vaccine.8 The MSP-
1 gene has 7 variable blocks that are separated either by 
conserved or semi-conserved regions.  Block 2, a region 
near the N-terminal of  the MSP-1 gene, is the most poly-
morphic part of  the antigen and appears to be under the 
strongest diversifying selection within natural popula-
tions. Up to now, four different allelic types of  block 2 
have been identified: MAD20, K1, RO33 and MR.9
 
MSP-2 of  P. falciparum is another leading candidate an-
tigen for subunit malaria vaccine.10 It comprises highly 
polymorphic central repeats flanked by unique variable 
domains and conserved N- and C-terminal domains.11 
The MSP-2 alleles generally fall into two allelic types, 
FC27 and 3D7, which differ considerably in the dimor-
phic structure of  the variable central region, block 3. 
Due to their polymorphic features, the MSP-1 and MSP-
2 genes have been employed as polymorphic markers in 
studies of  malaria transmission dynamics in natural iso-
lates of  P. falciparum.
Merozoite surface proteins 1 and 2 (MSP-1 and MSP-2) 
are widely used to study the allelic diversity and frequency 
of  P. falciparum which are most commonly correlated with 
the level of  transmission in the area under study. The two 
loci have also been introduced as a discriminatory tool to 
distinguish new from recrudescent infections.4
Glutamate Rich Protein (GLURP) is a 220-kDa exoan-
tigen found in the parasitophorous vacuole. The single 
full-length GLURP sequence available to date (strain 
F32) shows two amino acid repeat regions (R1 and R2) 
with degenerate repeat motifs found in both. Diversity in 
GLURP has been indicated by different sized polymerase 
chain reaction (PCR) products from the R2 region of  
various laboratory-adapted12 and field strains.13 The gluta-
mate-rich protein (GLURP) is expressed in all stages of  
the Plasmodium falciparum life cycle in humans. 
This study was carried out because limited reports are 
available on genetic diversity of Plasmodium falciparum in 
Nigeria with no information on genetic diversity of  Plas-
modium falciparum in Okelele Health Centre, Okelele, Ilo-
rin, Kwara State, Nigeria.
Methodology 
Study setting:  This study was conducted at the Gen-
eral Outpatient ward of  Okelele Health Centre, Ilorin, 
Kwara State between the period of  October and Novem-
ber, 2012.  Ilorin, Kwara State, Nigeria where Okelele 
Health Centre, is located is a malaria holoendemic city.14 
The majority of  the people living in Okelele, Ilorin are 
artisans, peasant farmers, petty traders and civil servants. 
The mainstay of  the economy is agriculture.
Sample collection: 200 patients presenting with symp-
toms of  malaria were recruited based on the doctors’ 
clinical investigation.  5mls of  the blood sample of  each 
patient were collected by venipuncture.  Rapid Diagnos-
tic Testing using CareStartTM HRDP – 2 kits were done. 
Also, thick and thin blood films for parasite detection, 
identification and classification of  degree of  parasitaemia 
were also prepared for Giemsa staining as described by 
Cheesebrough.15  About 3mls of  blood were dispensed 
unto 3MM Whatman Filter paper for genomic extraction. 
Questionnaires were administered to all the patients.
Classification of  degree of  parasitaemia  
Parasite density was determined using the formula: 
Classification of  degree of  parasitaemia               
Parasite density was determined using the formula:
 X  
The malaria parasite density was graded as follows:
1) ≤ 1000 parasites/µl of  blood: low density
2) 1, 000 – 9,999 parasites/µl of  blood: medium density
3) > 10, 000parasites/µl of  blood: high density.16
 
DNA Extraction from Plasmodium falciparum iso-
lates:  
Parasite genomic DNA was extracted from 50 dried 
blood spotted filter paper samples representative of  the 
day of  presentation using the methanol extraction meth-
od of  Gil et al.17 from patients with the highest parasi-
taemia levels. Approximately, 3mm2 of  each dried blood 
spotted filter paper strips were cut using small perforating 
machine, each filter paper punch was soaked in 125µL 
of  methanol. After incubation at room temperature for 
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15 minutes, the methanol was removed and the samples 
were dried before adding 65µL of  distilled water. The 
punches were mashed using a new pipette tip for each 
punch and heated at 97°C for 15 minutes to elute the 
DNA; the punches were removed and the content centri-
fuged for 30seconds at 14800rpm. 
Allelic typing of  MSP-1, MSP-2 and GLURP: 
The oligonucleotide primers specific for the polymorphic 
regions were used (see Table 1). The three genes were 
amplified by nested PCR. An initial amplification of  the 
outer regions of  the two genes was followed by a nested 
PCR with family-specific primer pairs. All reactions were 
carried out in a final volume of  50μl of  the master mix 
containing 12mM dNTP, 15μM of  each primer, 22.5mM 
MgCl2, 37.5mM Buffer, 220µl PCR water, and 3U of  
Taq DNA polymerase. In the first round reaction, 2μl of  
genomic DNA was added as a template. In the nested 
reaction, 1μl of  the first PCR product was added. Each 
amplification profile consisted of  initial denaturation at 
940C for 2 min, 940C for 30secs, 580C for 1min, 720C 
for 2mins followed immediately by 9 cycles of  940C for 
30secs, 58°C for 1 min 30secs, and 720C for 2min fol-
lowed immediately by 24 cycles of  940C for 30secs, 580C 
for1min 30secs, and 720C for 2min. The final cycle had 
a prolonged extension at 720C for 7 min for Outer PCR 
cycling conditions. Inner PCR cycling conditions has the 
following protocol: Initial denaturation at 940C for 2 min, 
940C for 30secs, 590C for 1min, 720C for 2mins followed 
immediately by 9 cycles of  940C for 30secs, 58°C for 1 
min 30secs, and 720C for 2min followed immediately by 
24 cycles of  940C for 30secs, 600C for1min 30secs, and 
720C for 2min. The final cycle had a prolonged exten-
sion at 720C for 7 min for Inner PCR cycling conditions. 
This was used as template in PCR reactions to type mo-
lecular makers.  The amplicons were sized against 100bp 
molecular weight marker on a 1.5% agarose gel made in 
0.5X TAE containing 6µls ethidium bromide and ran in a 
horizontal tank filled also with 0.5X TAE for up to 1hour 
at 95V. All gels were visualized under UV (ultraviolet) 
transillumination. 
 
Allelic distribution, Multiplicity of  Infection and 
heterozygosity:  The prevalence of  each allelic type was 
determined as the presence of  PCR products for the type 
in the total number of  amplified bands for the corre-
sponding locus.18  
The Multiplicity of  Infection (MOI) or number of  geno-
types per infection was calculated by dividing the total 
number of  fragments detected in MSP - 1, MSP – 2 and 
GLURP by the number of  samples positive for the same 
marker. 
 
Heterozygosity was used as a measure of  genetic diversity 
and it represents the probability of  being infected by two 
parasites with different alleles at a given locus and ranges 
between 0 and 1 was calculated by use of  the formula
HE = [n/(n-1)] [(1-ΣPi2)]
            Where n is the number of  isolates sampled
pi is the allele frequency at a given locus.5,19
Isolates with more than one genotype were considered as 
polyclonal infection while the presence of  a single allele 
was considered as monoclonal infection.16
Ethical consideration: The study obtained an ethical 
clearance from the Ethical Review Committee (ERC) 
of  the University of  Ilorin Teaching Hospital.  Also, in-
formed consents were obtained from individual patients/
guardians after a clear explanation of  the objectives and 
logistics of  the study have been carefully explained to 




For malaria microscopy, 154 (77%) were positive and 46 
(23%) were negative. The level of  parasitaemia varied 
between 40parasites/µl to 566,000parasites/µl.  Out of  
the samples positive for microscopy, 83(41.5%)had low 
parasitaemia of  <1000, 32 (16.0%) had moderate parasi-
taemia of  ≤ 9999 while 39 (19.5%) had high parasitaemia 
≥ 10, 000. Parasite genomic DNA was extracted from the 
50 blood samples with the highest parasitaemia levels
For MSP – 1, KI, MAD20 and RO33 allelic types were 
identified. 39(81%) of  the blood samples were positive 
for MSP – 1, i.e. the blood sample carried at least one of  
the 3 allelic types of  MSP – 1.  K1 allele type was identi-
fied in 27(56.25%) of  the blood samples, MAD20 allele 
in 20(42% ) while RO33 was identified in 23(48%) of  the 
blood samples.  Only 8(16.667%) of  the blood samples 
were positive for all the three allelic types of  MSP – 1. 
6(12.5%) had mixed infections with K1 and MAD20, 
6(12.5%) also had mixed infections with KI and RO33 
while 3(6.25%) had mixed infections with MAD20 and 
RO33 allele types. 11(23% ) of  the blood samples showed 
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2 or more PCR products as visualised on agarose gel as 
double bands or multiple bands.  K1 had the highest al-
lelic frequency (56%) from the blood samples followed 
by RO33 (48%) and MAD20 (42%) with Multiplicity of  
Infection being 1.33, 1.3 and 1 respectively.
For MSP – 2, both FC27 and 3D7 allelic types were iden-
tified 31(64.58%) of  the blood samples were positive for 
MSP – 2, i.e. the blood sample carried at least one of  the 
2 allelic types of  MSP – 2.  FC27 allele type was identified 
in 18 (37.50%) of  the blood samples while the 3D7 allele 
type was found in 10(20.83%).  Both alleles were found 
in 3(6.25%) of  the samples.   13(27.1%) of  the blood 
samples showed 2 or more PCR products as visualized 
on agarose gel as double bands or multiple bands.  FC27 
had the highest allelic frequency (43.8%) while 3D7 had 
the lowest allelic frequency (27.1%). MOI was 1.8 and 1.5 
respectively for FC27 and 3D7 respectively.
16(41% ) of  the blood samples testing positive for MSP 
– 1 harboured a single allele which signifies a monoclonal 
infection with Plasmodium falciparum whereas polyclonal 
infection was detected in the remaining 23(59%).  On the 
other hand, 28(90%) of  the MSP – 2 positive samples had 
monoclonal infection.
The frequency of  samples having the GLURP allele was 
19(39.53%) with 14(29%) showing 2 or more PCR prod-
ucts as visualised on agarose gel as double bands or mul-
tiplebands indicating polyclonal infection.  MOI was 2.05. 
The multiplicity of  infection (MOI) was 1.70, 1.8 and 2.05 
for MSP – 1, MSP – 2 and GLURP respectively (Table 1). 
Expected heterozygosity (He) was 0.29, 0.75 and 0.86 
for MSP – 1, MSP – 2 and GLURP respectively.  All are 
shown in Table 2.
Table 1. Sequences of the primers used to amplify the msp-1 andmsp-2  
genes of P. falciparum isolates 
 
Locus Primer Primer sequence 
Primary PCR                                                                                                                  
msp-1 msp1-P1 5′ -CACATGAAAGTTATCAAGAACTTGTC-3′ 
  msp1-P2 5′ -GTACGTCTAATTCATTTGCAC-3′ 
msp-2 msp2-1 5′ -ATGAAGGTAATTAAAACATTGTCTATTATA-3′ 
  msp2-4 5′ -ATATGGCAAAAGATAAAACAAGTG-3′ 
      
Secondary PCR 
msp-1 K1-K1 5′ -GAAATTACTACAAAAGGTGCAAGTG-3′ 
  K1-K2 5′ -AGATGAAGTATTTGAACGAGGTAAAGTG-3′ 
  MAD20-M1 5′ -GAACAAGTCGAACAGCTGTTA-3′ 
  MAD20-M2 5′ -TGAATTATCTGAAGGATTTGTACGTCTTGA-3′ 
  R033-R1 5′ -GCAAATACTCAAGTTGTTGCAAAGC-3′ 
  R033-R2 5′ -AGGATTTGCAGCACCTGGAGATCT-3′ 
msp-2 3D7-A1 5′ -GCAGAAAGTAAGCCTTCTACTGGTGCT-3′ 
  3D7-A2 5′ -GATTTGTTTCGGCATTATTATGA-3′ 
  FC27-B1 5′ -GCAAATGAAGGTTCTAATACTAATAG-3′ 
  FC27-B2 5′ -GCTTTGGGTCCTTCTTCAGTTGATTC-3′ 
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Table 2: Allelic typing and diversity profiles of Plasmodium falciparum isolates from 
Okelele, Health Centre, Ilorin based on genetic diversity of MSP-1, MSP-2 and GLURP 
 














(He)   
MSP – 1          1.70 0.29 
K1 7 160 – 225 14.58       1.3   
MAD2O 3 140 – 250 6.250       1.3   
R033 6 160 12.50        1.0   
K1+MAD2O 6   12.50         2.2     
KI+RO33 6   12.50         2.8     
MAD20+R033 3   6.25         2.3     
KI+MAD20+RO33 8      16.67         3.4     
NEGATIVE 9      18.75       
TOTAL 48     100.00       
  
MSP – 2         
        
      1.8 
  
     0.75   
FC27 18 200 – 400 37.50       1.8   
3D7 10 250 – 500 20.83       1.5   
FC27+3D7 3   6.25       2.3     
NEGATIVE 17   35.42       













     
      2.05 
      
       0.86   
TOTAL 48     100.00       








Allelic typing displayed the polymorphic nature of  Plas-
modium falciparum in Okelele blood Samples in respect 
to MSP – 1, MSP 2 and GLURP.  Of  the 50 samples 
taken for PCR, 96% (48/50) showed amplification while 
4% (2/50) showed no amplification.  
In this study, genetic polymorphism of  two Merozoite 
Surface Proteins, MSP – 1, MSP – 2 and Glutamate Rich 
Protein (GLURP) of  48 Plasmodium falciparum  isolates 
were analysed.  Allele specific PCR typing of  MSP – 1 
showed the presence of  K1, MAD20 and RO33 allelic 
families in the isolates.  Of  the three allelic families of  
MSP – 1, K1 was the predominant allelic family as it was 
identified in 27(56.25%).  This is in agreement with pat-
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terns observed in isolates from South Western Nigeria20 
and West Uganda21 but in contrast to patterns observed 
from Pahang, Malaysia16 and some African populations 
such as The Gambia, Gabon, North Eastern Sudan, 
North Eastern Tanzania, South Africa and Nigeria inclu-
sive.11
Allelic typing of  MSP – 2 showed the presence of  FC27 
and 3D7 allelic families occurring together and indepen-
dently.  The frequency of  FC27 and 3D7 were 18(37.50%) 
and 10(20.83%). 3(6.25%) of  the isolates had FC27 and 
3D7 occurring together.  Similar patterns were observed 
in Brazil22 where FC27 was more prevalent than 3D7 
but not in Thailand,23 Myanmar24 and Cameroon25 where 
they recorded higher prevalence with 3D7.   Glutamate 
Rich Protein (GLURP) was observed in 19(39.58%) of  
the Plasmodium falciparum isolates from Okelele Health 
Centre, Ilorin.  This proportion was low when compared 
with isolates from other parts of  Sub-Saharan Africa5 and 
South Western Nigeria20 where 73.7% and 80.0% of  iso-
lates respectively coded for GLURP.  These results col-
lectively suggest that diverse allelic variations of  MSP – 1, 
MSP – 2 and GLURP exist in Plasmodium falciparum 
isolates from Okelele Health Centre, Ilorin.  Multiplicity 
of  infection (MOI) was highest for GLURP (2.05) and 
lowest for MSP – 1 (1.70).  MOI for MSP – 2 was 1.80.   
The MOI values were low for MSP – 1 and MSP – 2 
when compared with values from south western Nigeria 
(2.1 and 2.2 respectively),20 West Uganda21 but were high-
er than values gotten from Malawi (1.03 and 1.52 respec-
tively).5  Also, the MOI values for MSP – 1 and MSP – 2 
were different from those gotten from Pahang, Malaysia 
(1.37 and 1.20 respectively)16.  GLURP MOI was 2.05 and 
this was higher than values obtained from South West-
ern Nigeria (1.3 by Olasehinde et al.20), Malawi, Burkina 
Faso, Sao tome and Principe, Tanzania and Uganda (1.01, 
1.86, 1.01, 1.84 and 1.29 respectively) by Mwingira et al.5 
Expected heterozygosity (He) was used as a measure of  
genetic diversity of  Plasmodium falciparum isolates from 
Okelele Health Centre, Ilorin. He values were 0.29, 0.75 
and 0.86 respectively for MSP – 1, MSP – 2 and GLURP 
respectively.  He values were lowest in MSP – 1 locus.  He 
values for MSP – 1 is very low when compared to values 
from endemic areas such as Malawi and Burkina Faso; 
0.79 and 0.78 respectively,5 Malaysia (0.57) and other ar-
eas of  South East Asia/Pacific Region.16  He values for 
MSP – 2 (0.75) was higher than that reported by Atroosh 
et al.16 in Malaysia but was lower than those observed 
from other countries such as Malawi, Burkina Faso, Sao 
Tome, Tanzania, Uganda in Sub Saharan Africa (0.97, 
0.98, 0.96, 0.99 and 0.95 respectively).  GLURP He values 
were higher and similar to those reported by Mwingira et 
al.5 from Malawi and Uganda but lower for values got-
ten from Tanzania, Burkina Faso and Sao Tome.  These 
results collectively suggest that there is high genetic diver-
sity in MSP – 2 and GLURP allelic families of Plasmodium 
falciparum isolates from Okelele Health Centre, Ilorin, Ni-
geria. 
Conclusion
PCR has been shown to be very reliable in ascertaining 
the diversity of  Plasmodium falciparum species in patients 
attending Okelele Health Centre, Ilorin.  It has also pro-
vided a baseline data of  the diversity of  Plasmodium fal-
ciparum species in Okelele, Ilorin which will go a long 
way in future research into the genomic diversity of  Plas-
modium falciparum. 
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